• 
  Kelly Charniga, Sang Woo Park, Andrei R Akhmetzhanov, Anne Cori, Jonathan Dushoff, et al.. Best practices for estimating and reporting epidemiological delay distributions of infectious diseases using public health surveillance and healthcare data. 2024. ⟨hal-04572940⟩
• 
  Marta Nunes, Edward Thommes, Holger Fröhlich, Antoine Flahault, Julien Arino, et al.. Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report. Infectious Disease Modelling, 2024, 9 (2), pp.501-518. ⟨10.1016/j.idm.2024.02.008⟩. ⟨hal-04551033⟩
• 
  Thierry Lefrançois, Bruno Lina, Brigitte Autran, Y. Caille, F. Carrat, et al.. One Health approach at the heart of the French Committee for monitoring and anticipating health risks [commentaire]. Nature Communications, 2023, 14, 7540 [4 p.]. ⟨10.1038/s41467-023-43089-2⟩. ⟨hal-04372011⟩
• 
  Antoine Brault, Isabelle Pontais, Vincent Enouf, Christine Debeuret, Emma Bloch, et al.. Estimates of effectiveness and impact of nirsevimab on hospitalisations for RSV bronchiolitis in metropolitan France, 2023-2024 : a modelling study. 2024. ⟨pasteur-04501465⟩
• 
  Juliette Paireau, Cécile Durand, Sylvain Raimbault, Joséphine Cazaubon, Guillaume Mortamet, et al.. Nirsevimab effectiveness against cases of respiratory syncytial virus bronchiolitis hospitalised in pediatric intensive care units in France, September 2023 -January 2024. 2024. ⟨pasteur-04501286⟩

132

12